Telix Pharmaceuticals Limited
TLX
$10.67
-$0.07-0.65%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 141.87M | 141.87M | 207.16M | 207.16M | 440.00M |
| Total Receivables | 138.37M | 138.37M | 129.52M | 129.52M | 99.65M |
| Inventory | 37.08M | 37.08M | 35.23M | 35.23M | 23.62M |
| Prepaid Expenses | 12.96M | 12.96M | -- | -- | 6.84M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 26.10M | 26.10M | -- |
| Total Current Assets | 330.28M | 330.28M | 398.01M | 398.01M | 570.12M |
|
|
|||||
| Total Current Assets | 330.28M | 330.28M | 398.01M | 398.01M | 570.12M |
| Net Property, Plant & Equipment | 115.61M | 115.61M | 74.18M | 74.18M | 33.65M |
| Long-term Investments | 198.99M | 198.99M | 185.81M | 185.81M | 66.59M |
| Goodwill | 198.99M | 198.99M | 185.81M | 185.81M | 66.59M |
| Total Other Intangibles | 393.84M | 393.84M | 398.36M | 398.36M | 191.27M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 121.59M | 121.59M | 129.53M | 129.53M | 74.98M |
| Total Assets | 1.16B | 1.16B | 1.19B | 1.19B | 940.38M |
|
|
|||||
| Total Accounts Payable | 71.66M | 71.66M | 51.69M | 51.69M | 42.23M |
| Total Accrued Expenses | 52.63M | 52.63M | 59.09M | 59.09M | 47.94M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 18.66M | 18.66M | 21.06M | 21.06M | 13.31M |
| Total Finance Division Other Current Liabilities | 88.68M | 88.68M | 166.75M | 166.75M | 101.62M |
| Total Other Current Liabilities | 88.68M | 88.68M | 166.75M | 166.75M | 101.62M |
| Total Current Liabilities | 231.62M | 231.62M | 298.58M | 298.58M | 205.09M |
|
|
|||||
| Total Current Liabilities | 231.62M | 231.62M | 298.58M | 298.58M | 205.09M |
| Long-Term Debt | 391.91M | 391.91M | 371.48M | 371.48M | 341.81M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 56.53M | 56.53M | 25.71M | 25.71M | 5.04M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 68.54M | 68.54M | 72.24M | 72.24M | 35.50M |
| Total Liabilities | 748.61M | 748.61M | 768.01M | 768.01M | 587.44M |
|
|
|||||
| Common Stock & APIC | 479.96M | 479.96M | 473.11M | 473.11M | 414.01M |
| Retained Earnings | -154.54M | -154.54M | -150.98M | -150.98M | -152.91M |
| Treasury Stock & Other | 89.95M | 89.95M | 99.81M | 99.81M | 91.84M |
| Total Common Equity | 415.38M | 415.38M | 421.94M | 421.94M | 352.94M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 415.38M | 415.38M | 421.94M | 421.94M | 352.94M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 415.38M | 415.38M | 421.94M | 421.94M | 352.94M |
|
|
|||||